Form 4: Nuvalent's Chief Legal Officer, Deborah Ann Miller, Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Deborah Ann Miller, Chief Legal Officer of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On September 9, 2024, Deborah Ann Miller, the Chief Legal Officer of Nuvalent, Inc., executed a transaction involving the company's Class A Common Stock.
- Miller exercised a stock option to acquire 3,000 shares at a price of $6.89 per share.
- Concurrently, Miller sold a total of 3,000 shares in multiple transactions at weighted average prices ranging from $86.34 to $89.11.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 27, 2023.
- Following these transactions, Miller directly owns 33,300 shares of Class A Common Stock and holds options for 173,608 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an officer. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity under a pre-arranged plan.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives and their potential alignment with shareholder interests. The use of a 10b5-1 trading plan suggests a pre-planned and systematic approach to stock transactions, mitigating concerns about opportunistic trading based on inside information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by a company officer, but the existence of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| December 27, 2023 | Date the reporting person adopted the Rule 10b5-1 trading plan. |
| September 9, 2024 | Date of the stock option exercise and sale of shares. |
| September 11, 2024 | Date of the Form 4 filing. |
| April 29, 2031 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.